Combination of a Novel Fusion Protein CD3 epsilon zeta 28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells
Release time:2024-08-05 Hits:
Affiliation of Author(s):43400
Journal:CANCERS
ISSN No.:2072-6694
Translation or Not:no
